La prevalencia del síndrome de antifosfolípidos en pacientes con lupus eritematoso sistémico en el Hospital Universitario de Puerto Rico / Prevalence of antiphospholipid syndrome in patients with systemic lupus erythematosus at the University Hospital of Puerto Rico
P. R. health sci. j
; 19(4): 341-344, Dec. 2000.
Article
em Es
| LILACS
| ID: lil-334083
Biblioteca responsável:
BR1.1
ABSTRACT
This is a retrospective study based on a population of 80 patients with connective tissue diseases from the University Hospital of Puerto Rico. Among the population, 62 (77.5) of the patients had Systemic Lupus Erythematosus (SLE), whom we were most interested to monitor. The investigation revealed an incidence of 13.8 of anthiophospholipid syndrone within the general population. Among the patients with SLE it was 12.9, and only 5.5 among the population with other diagnoses. The antibody found with the highest frequency within the systemic lupus erythematosus population was the anticardiolipin IgG (30.6) and lupus anticoagulant (17.7). The antibody frequency among patients with other diagnoses was only 5.5 for lupus anticoagulant and 5.5 for anticardiolipin IgM (the only one found). Among SLE's clinical manifestations, the most frequently found were thrombocitopenia and pregnancy complications.
Buscar no Google
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Lúpus Eritematoso Sistêmico
Tipo de estudo:
Incidence_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limite:
Humans
País/Região como assunto:
Caribe
/
Puerto rico
Idioma:
Es
Ano de publicação:
2000
Tipo de documento:
Article